Cancer Institute of New Jersey (CINJ), Division of Surgical Oncology, Melanoma & Soft Tissue Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Division of Surgical Oncology, Melanoma & Soft Tissue Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Projects

  • Research Output

    Activation of Grm1 expression by mutated BRaf (V600E) in vitro and in vivo

    Chen, H. C., Sierra, J., Yu, L. J., Cerchio, R., Wall, B. A., Goydos, J. & Chen, S., Jan 1 2018, In : Oncotarget. 9, 5, p. 5861-5875 15 p.

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    A phase II trial of riluzole, an antagonist of metabotropic glutamate receptor 1 (GRM1) signaling, in patients with advanced melanoma

    Mehnert, J. M., Silk, A. W., Lee, J. H., Dudek, L., Jeong, B. S., Li, J., Schenkel, J. M., Sadimin, E., Kane, M., Lin, H., Shih, W. J., Zloza, A., Chen, S. & Goydos, J. S., Jul 2018, In : Pigment Cell and Melanoma Research. 31, 4, p. 534-540 7 p.

    Research output: Contribution to journalArticle

  • 9 Scopus citations

    Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness

    Isola, A. L., Eddy, K., Zembrzuski, K., Goydos, J. S. & Chen, S., Jan 1 2018, In : Oncotarget. 9, 1, p. 1187-1199 13 p.

    Research output: Contribution to journalArticle

  • 4 Scopus citations